---
figid: PMC11171673__ijms-25-05576-g001
figtitle: RhoA/Rho kinase signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11171673
filename: PMC11171673__ijms-25-05576-g001.jpg
figlink: /pmc/articles/PMC11171673/figure/F1
number: F1
caption: 'Schematic diagram of the RhoA/Rho kinase signaling pathway. When G protein-coupled
  receptors (GPCRs) bind to various ligands, such as endothelin-1 (ET-1), angiotensin
  II, and TGF-β, they activate guanine nucleotide exchange factors (GEFs) and, in
  turn, activate RhoA by converting it from an inactive GDP-bound state to an active
  GTP-bound form. This activation triggers the ROCK cascade, leading to the phosphorylation
  of downstream target proteins and subsequent cytoskeletal modifications. These changes
  cause contraction of the trabecular meshwork, reducing aqueous outflow through the
  conventional pathway and increasing intraocular pressure (IOP). ROCK inhibitors
  reduce IOP by blocking this cascade. GAP: GTPase-activating protein. ERM: ezrin-radixin-moesin.
  CPI-17: C-kinase-potentiated protein phosphatase one inhibitor of 17 kDa'
papertitle: The Application of Rho Kinase Inhibitors in the Management of Glaucoma
reftext: Li-Ching Liu, et al. Int J Mol Sci. 2024 Jun;25(11).
year: '2024'
doi: 10.3390/ijms25115576
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: glaucoma | rho kinase inhibitors | ROCK | intraocular pressure | neuroprotection
automl_pathway: 0.9307032
figid_alias: PMC11171673__F1
figtype: Figure
redirect_from: /figures/PMC11171673__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11171673__ijms-25-05576-g001.html
  '@type': Dataset
  description: 'Schematic diagram of the RhoA/Rho kinase signaling pathway. When G
    protein-coupled receptors (GPCRs) bind to various ligands, such as endothelin-1
    (ET-1), angiotensin II, and TGF-β, they activate guanine nucleotide exchange factors
    (GEFs) and, in turn, activate RhoA by converting it from an inactive GDP-bound
    state to an active GTP-bound form. This activation triggers the ROCK cascade,
    leading to the phosphorylation of downstream target proteins and subsequent cytoskeletal
    modifications. These changes cause contraction of the trabecular meshwork, reducing
    aqueous outflow through the conventional pathway and increasing intraocular pressure
    (IOP). ROCK inhibitors reduce IOP by blocking this cascade. GAP: GTPase-activating
    protein. ERM: ezrin-radixin-moesin. CPI-17: C-kinase-potentiated protein phosphatase
    one inhibitor of 17 kDa'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EDN1
  - ROCK1
  - ROCK2
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - ARHGEF2
  - SLC2A4RG
  - RHOA
  - MTG1
  - PPP1R14A
  - PPP1R12A
  - MLC1
  - LIMK1
  - ETV5
  - EZR
  - RDX
  - MSN
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - inhibitors
  - GDP
  - GTP
---
